Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravesical Lactobacillus for Urinary Symptoms in SCI
NCT04373512Phase 2Completed
- Sponsor
- MedStar Health Research Institute
- Start
- Jun 2020
- Primary completion
- Feb 2025
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of Lactobacillus rhamnosus GG in urinary tract infection (UTI), sponsored by MedStar Health Research Institute. Started Jun 2020; status: completed.
02
Drugs
Lactobacillus rhamnosus GG
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT04373512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04373512.